GENE ONLINE|News &
Investment Trends & Forecasts
JPM 2026 Reveals Biopharma’s High-Stakes Mix of IPO Risk, Market Turbulence, and Regulation
2026-01-19
Beyond the Main Stage: A Showcase of the Next Wave of Korean Biotech Innovation at JPM Week 2026
2026-01-15
2026 Cardiometabolic and Weight-Loss Watchlist: Trials That Could Mint the Next Trillion-Dollar Giant
2026-01-14
From Main Venue Presentations to Strategic Partnering, Taiwan’s Biotech Sector Makes Its Mark in JPM 2026
2026-01-13
From Pipeline to Payday: The Rare Disease Assets Most Likely to Spark a 2026 M&A Land-Grab
2026-01-13
Resilience Over Expansion: What J.P. Morgan’s 2026 Outlook Reveals About Business Strategy Amid Macro Uncertainty
2026-01-08
LATEST
Gut Microbiome Composition Predicts Long-term Cardiometabolic Health Outcomes in Diverse Urban Populations
2026-03-12
NVIDIA Ahead of GTC 2026: Markets Focus on Data Center Strength, PC Expansion, and the Next Technical Breakout
2026-03-12
Global and APAC Biopharma Watch: Capital Raising, Clinical Expansion, and Industry Moves in Focus
2026-03-12
EVENT
2026-04-09
4th Cell & Gene Therapy Innovation & Access Congress: Asia (Media Partnership)
Seoul, South Korea
